E. Golden
Immunology · 2013–2020
A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 142 citations into it
- Oncology — 95 citations into it
Whom E. Golden trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from E. Golden's perspective
Ordered by how strongly the researchers E. Golden trusts endorse each paper. Same corpus, a different order for every researcher.
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (Journal of Clinical Investigation)
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
- Combining radiotherapy and cancer immunotherapy: a paradigm shift. (Journal of the National Cancer Institute)
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma (New England Journal of Medicine)
- STAR: ultrafast universal RNA-seq aligner (Bioinform.)
- The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. (Genome Research)
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment (Science)
- Cell host & microbe
Their papers
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. (2016) — 757 citations
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (2015) — 3,116 citations
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) — 916 citations
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade (2018) — 797 citations
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. (2015) — 613 citations
- Role of Local Radiation Therapy in Cancer Immunotherapy. (2015) — 712 citations
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer (2013) — 638 citations